Concepedia

Maxi Zumpe

MZ

Statistics

Publications

14

Citations

443

H-Index

12

Active since

2016

Affiliations

Universitätsmedizin Greifswald(Current)

St Anna Children's Hospital

Cancer Research Institute of the Slovak Academy of Sciences

Apeiron Biologics (Austria)

Maxi Zumpe is an author at Universitätsmedizin Greifswald specializing in cancer immunotherapy, immunotherapy, and immunology.

ORCID

Publications per year

2016–2023

14

Publications

14

Detection of rat hepatitis E virus in wild Norway rats (Rattus norvegicus) and Black rats (Rattus rattus) from 11 European countries

René Ryll, Samuel Bernstein, Elisa Heuser et al. · Veterinary Microbiology · 2017 · 87 citations · Full text

, , +12

PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD<sub>2</sub> antibody ch14.18/CHO

Nikolai Siebert, Maxi Zumpe, Madlen Jüttner et al. · OncoImmunology · 2017 · 66 citations · Full text

, , +17

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2

Nikolai Siebert, Christin Eger, Diana Seidel et al. · mAbs · 2016 · 56 citations · Full text

, , +15

Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and improved event-free survival

Nikolai Siebert, Christian Fuglesang S. Jensen, Sascha Troschke‐Meurer et al. · OncoImmunology · 2016 · 56 citations · Full text

, , +15

Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 study

Holger N. Lode, Karoline Ehlert, Stephanie Huber et al. · British Journal of Cancer · 2023 · 25 citations · Full text

, , +12

1–5 of 14